Ouimette Mike

CIK 00018226191 companySOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001822619

Recent Transactions

29 trades

Award
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (Right to Buy)
2025-01-23+70,000→ 70,000 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2025-01-23+35,000→ 105,544 total
Sale
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2025-01-22$10.99/sh−10,230→ 70,544 total
Sale
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2025-01-17$11.20/sh−13,270→ 80,774 total
Sale
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2024-07-10$11.56/sh−7,656→ 94,044 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2024-07-09+14,954→ 101,700 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2024-01-23+31,500→ 86,746 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (Right to Buy)
2024-01-23+63,000→ 63,000 total
Sale
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2024-01-17$17.23/sh−5,197→ 55,246 total
Sale
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2023-07-20$17.55/sh−4,755→ 60,443 total
Sale
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2023-07-17$18.01/sh−12,778→ 65,198 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2023-07-14+27,187→ 77,976 total
Sale
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2023-04-03$26.74/sh−2,677→ 50,989 total
Sale
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2023-04-03$27.45/sh−200→ 50,789 total
Sale
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2023-03-30$26.52/sh−4,874→ 53,666 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2023-03-29+13,593→ 58,540 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2023-01-25+39,000→ 44,947 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (right to buy)
2023-01-25+55,000→ 55,000 total
Exercise/Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (right to buy)
2023-01-23−10,000→ 77,000 total
Exercise/Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2023-01-23$24.32/sh+10,000→ 25,947 total
Sale
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2023-01-23$34.19/sh−20,000→ 5,947 total
Exercise/Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2023-01-23$11.86/sh+10,000→ 15,947 total
Exercise/Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (right to buy)
2023-01-23−10,000→ 98,240 total
Sale
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2022-12-22$19.38/sh−2,928→ 5,947 total
Sale
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2022-12-20$19.10/sh−4,719→ 8,875 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2022-12-19+13,594→ 13,594 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (right to buy)
2022-01-26+87,000→ 87,000 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (right to buy)
2021-01-23+15,520→ 15,520 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (right to buy)
2020-10-09+108,240→ 108,240 total

Companies

PLIANT THERAPEUTICS, INC.
General Counsel & Corp. Sec'y
$PLRX

Recent Filings

Address

C/O PLIANT THERAPEUTICS, INC. 331 OYSTER POINT BOULEVARD

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov